Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2

Journal of Clinical Oncology

Volumn 27, Issue 32, 2009, Pages 5331-5336

  Walker, Joan L ^a   Piedmonte, Marion R ^a   Spirtos, Nick M ^a   Eisenkop, Scott M ^a   Schlaerth, John B ^a   Mannel, Robert S ^a   Spiegel, Gregory ^a   Barakat, Richard ^a   Pearl, Michael L ^a   Sharma, Sudarshan K ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT;

ABSCESS; ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CELLULITIS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; FEMALE; FEVER; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYSTERECTOMY; ILEUS; INTESTINE OBSTRUCTION; LAPAROSCOPY; LAPAROTOMY; LENGTH OF STAY; LUNG EMBOLISM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; ONCOLOGY; OPERATION DURATION; PARAAORTIC LYMPH NODE; PELVIS; PELVIS LYMPHADENECTOMY; PEROPERATIVE COMPLICATION; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SALPINGOOOPHORECTOMY; SEPSIS; SURGICAL INFECTION; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOPHLEBITIS; TREATMENT OUTCOME; URINARY TRACT FISTULA; URINARY TRACT INFECTION; UTERUS CANCER; CANCER STAGING; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY;

ABSCESS; AGED; FEMALE; FEVER; HUMANS; INTRAOPERATIVE COMPLICATIONS; LAPAROSCOPY; LAPAROTOMY; LENGTH OF STAY; MIDDLE AGED; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); URINARY TRACT INFECTIONS; UTERINE NEOPLASMS;

EID: 73949107889     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.3248     Document Type: Article

References (31)

1. American Cancer Society: Cancer facts and figures 2007. Atlanta, GA, American Cancer Society, 2007
2. Morrow CP, Bundy BN, Kurman FJ, et al: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 40:55-65, 1991
3. Creasman WT, Morrow CP, Bundy BN, et al: Surgical pathologic spread patterns of endometrial cancer. Cancer 60:2035-2041, 1987
4. Creasman WT, Odicino F, Maisonneuve P, et al: Carcinoma of the corpus uteri. Int J Gynaecol Obstet 83:79-118, 2003 (suppl 1)
5. American Joint Committee on Cancer: Cancer Staging Manual (ed 6). New York, NY, Springer-Verlag, 2002
6. Keys HM, Roberts JA, Brunetto VL, et al: A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 92:744-751, 2004
7. Aalders J, Abeler V, Kolstad P, et al: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419-427, 1980
8. Randall ME, Filiaci VL Muss H, et al: Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. J Clin Oncol 24:36-44, 2006
9. Straughn JM, Huh WK, Orr JW Jr, et al: Stage IC adenocarcinoma of the endometrium: Survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol 89:295-300, 2003
10. Fanning J, Hoffman ML, Andrews SJ, et al: Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: Postoperative brachytherapy vs. observation. Gynecol Oncol 93: 632-636, 2004
11. Cragun JM, Havrilesky LJ, Calingaert B, et al: Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23:3668-3675, 2005
12. Bristow RE, Zerbe MJ, Rosenshein NB, et al: Stage IVB endometrial carcinoma: The role of cytoreductive surgery and determinants of survival. Gynecol Oncol 78:85-91, 2000
13. Awtrey CS, Cadungog MG, Leitao MM, et al: Surgical resection of recurrent endometrial carcinoma. Gynecol Oncol 102:480-488, 2006
14. Lambrou NC, Gomez-Marin O, Mirhashemi R, et al: Optimal surgical cytoreduction in patients with stage III and stage IV endometrial carcinoma: A study of morbidity and survival. Gynecol Oncol 93: 653-658, 2004
15. Thomas MB, Mariani A, Cliby WA, et al: Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Gynecol Oncol 107:190-193, 2007
16. Dargent D: Laparoscopic surgery and gynecologic cancer. Curr Opin Obstet Gynecol 5:294-300, 1993
17. Querleu D, Leblanc E, Castelain B: Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. Am J Obstet Gynecol 164:579-581, 1991
18. Childers JM, Spirtos NM, Brainard P, et al: Laparoscopic staging of the patient with incompletely staged early adenocarcinoma of the endometrium. Obstet Gynecol 83:597-600, 1994
19. Spirtos NM, Schlaerth JB, Spirtos TW, et al: Laparoscopic bilateral pelvic and paraaortic lymph node sampling: An evolving technique. Am J Obstet Gynecol 173:105-111, 1995
20. Gynecologic Oncology Group: Guidelines for Laparoscopic Pelvic and Aortic Lymph Node Sampling. https://gogmember.gog.org/manuals/pdf/surgman.pdf
21. National Cancer Institute: Common Toxicity Criteria version 2.0. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ ctcv20-4-30-992.pdf
22. Chan JK, Lin YG, Monk BJ, et al: Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women. Obstet Gynecol 97:707-711, 2001
23. Bloss JD, Berman ML, Bloss LP, et al: Use of vaginal hysterectomy for the management of stage I endometrial cancer in the medically compromised patient. Gynecol Oncol 40:74-77, 1991
24. Kornblith AB, Huang HQ, Walker JL, et al: Quality of life of patients with endometrial cancer undergoing laparoscopic staging compared to laparotomy: A Gynecologic Oncology Group study. J Clin Oncol (in press)
25. Creutzberg CL: Lymphadenectomy in apparent early-stage endometrial carcinoma: Do numbers count? J Clin Oncol 23:3653-3655, 2005
26. Partridge EE, Shingleton HM, Menck HR: The National Cancer Data Base report on endometrial cancer. J Surg Oncol 61:111-123, 1996
27. Maggino T, Romagnolo C, Landoni F, et al: An analysis of approaches to the management of endometrial cancer in North America: A CTF study. Gynecol Oncol 68:274-279, 1998
28. Kitchener H, Swart AM, Qian Q, et al: Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomized study. Lancet 373:125-136, 2009
29. Benedetti Panici P, Basile S, Maneschi F, et al: Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial. J Natl Cancer Inst 100: 1707-1716, 2008
30. Kilgore LC, Partridge EE, Alvarez RD, et al: Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56:29-33, 1995
31. Mariani A, Dowdy SC, Cliby WA, et al: Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging. Gynecol Oncol 109:11-18, 2008